BIOSYNTIA

biosyntia-logo

Biosyntia is a biotech startup within synthetic biology and metabolic engineering. We develop biocatalysts at an unprecedented speed and efficiency by employing our patent pending high-throughput screening technology. By developing tailored processes based on biocatalysis, Biosyntia enables production of complex chemical compounds by fermentation. Biocatalysis may substantially reduce both production costs and environmental impact compared to other processes such as chemical synthesis. We par... tner with manufacturers of fine chemical compounds (flavors, fragrances, APIs, pigments, additives, intermediates, and more) in order to establish more sustainable manufacturing processes for a greener tomorrow. Biosyntia is located at the Novo Nordisk Foundation (NNF) Center for Biosustainability in Hørsholm, 25 kilometers north of Copenhagen.

#SimilarOrganizations #People #Financial #Website #More

BIOSYNTIA

Industry:
Biopharma Biotechnology Clinical Trials Manufacturing

Founded:
2012-01-01

Address:
Hørsholm, Hovedstaden, Denmark

Country:
Denmark

Website Url:
http://www.biosyntia.com

Total Employee:
11+

Status:
Active

Total Funding:
18.27 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Euro Microsoft Exchange Online Amazon Office 365 Mail


Similar Organizations

demetrix-logo

Demetrix

Demetrix is a biotechnology company dedicated to researching and producing bioactive ingredients.

themis-bioscience-logo

Themis Bioscience

Themis Bioscience is a start-up biotechnology company.

Current Employees Featured

martin-plambech_image

Martin Plambech
Martin Plambech CEO @ Biosyntia
CEO
2017-07-01

jochen-förster_image

Jochen Förster
Jochen Förster CTO @ Biosyntia
CTO
2021-09-01

andreas-laustsen_image

Andreas Laustsen
Andreas Laustsen Co-founder & Business Developer @ Biosyntia
Co-founder & Business Developer

hans-genee_image

Hans Genee
Hans Genee Co-founder and CSO @ Biosyntia
Co-founder and CSO
2012-11-01

morten-o-a-sommer_image

Morten O. A. Sommer
Morten O. A. Sommer Co-Founder @ Biosyntia
Co-Founder
2012-12-01

henrik-dalbøge_image

Henrik Dalbøge
Henrik Dalbøge Chairman @ Biosyntia
Chairman

Founder


andreas-laustsen_image

Andreas Laustsen

hans-genee_image

Hans Genee

morten-o-a-sommer_image

Morten O. A. Sommer

Investors List

sofinnova-partners_image

Sofinnova Partners

Sofinnova Partners investment in Series B - Biosyntia

european-circular-bioeconomy-fund_image

European Circular Bioeconomy Fund

European Circular Bioeconomy Fund investment in Series B - Biosyntia

novo-a-s_image

Novo Holdings

Novo Holdings investment in Series B - Biosyntia

novo-a-s_image

Novo Holdings

Novo Holdings investment in Series A - Biosyntia

sofinnova-partners_image

Sofinnova Partners

Sofinnova Partners investment in Series A - Biosyntia

novo-ventures_image

Novo Ventures

Novo Ventures investment in Seed Round - Biosyntia

novo-a-s_image

Novo Holdings

Novo Holdings investment in Seed Round - Biosyntia

Official Site Inspections

http://www.biosyntia.com Semrush global rank: 4.27 M Semrush visits lastest month: 2.71 K

  • Host name: aacb0a264e514dd48.awsglobalaccelerator.com
  • IP address: 75.2.70.75
  • Location: Seattle United States
  • Latitude: 47.54
  • Longitude: -122.3032
  • Metro Code: 819
  • Timezone: America/Los_Angeles
  • Postal: 98108

Loading ...

More informations about "Biosyntia"

Biosyntia - Crunchbase Company Profile & Funding

Biosyntia is a biotech startup within synthetic biology and metabolic engineering. We develop biocatalysts at an unprecedented speed and efficiency by employing our patent pending high-throughput screening technology. By developing …See details»

A Natural Alternative - Biosyntia

Biosyntia was founded by Morten Sommer, Hans Genee and Andreas Hougaard Laustsen as a spin-out from the Centre for Biosustainability, at the Technical University of Denmark. Today we are 20 passionate people with capabilities …See details»

Our team - Biosyntia

Hans co-founded Biosyntia and currently heads the R&D. E-mail: hjg(at)biosyntia.com. Show more Show less. Joe Power. Sales Director. Email: [email protected]. Joe has previously …See details»

Biosyntia - LinkedIn

Biosyntia is a biotech startup within synthetic biology and metabolic engineering. We develop biocatalysts at an unprecedented speed and efficiency by employing our patent pending high-throughput ...See details»

Biosyntia Company Profile 2024: Valuation, Funding & Investors

Biosyntia General Information Description. Developer of a fermentation-based platform intended to produce natural active ingredients for various applications. The company offers a …See details»

Biosyntia Company Profile - Office Locations, Competitors ... - Craft

Biosyntia is a biotech company that specializes in synthetic biology and metabolic engineering. It produces B-vitamins and selected nutraceuticals from renewable sugar using a biological …See details»

Biosyntia - VentureRadar

Biosyntia is a biotech startup within synthetic biology and metabolic engineering. We develop biocatalysts at an unprecedented speed and efficiency by employing our patent pending high …See details»

Biosyntia - Funding, Financials, Valuation & Investors - Crunchbase

Biosyntia is a biotech startup within synthetic biology and metabolic engineering. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. ... How …See details»

Biosyntia - Contacts, Employees, Board Members, Advisors & Alumni

Biosyntia is a biotech startup within synthetic biology and metabolic engineering.See details»

Biosyntia ApS | DANISH BIO - Dansk Biotek

Biosyntia is a biotech startup within synthetic biology and metabolic engineering. The company develops biocatalysts at an unprecedented speed and efficiency by employing its patent …See details»

News - Biosyntia

Biosyntia raises 17.5 mEUR in series B for advancing sustainable ingredient production of active ingredients. ... We are thrilled to announce we are growing our R&D organization and that …See details»

Biosyntia raises €4 million in Series A financing to advance its ...

Biosyntia has today announced a Series A investment in the company of 4 million euros from Sofinnova Partners, a new investor, and Novo Seeds, an existing investor. The investment will …See details»

Biosyntia closes a 11.5 million EUR round to launch world

Jul 7, 2022 Biosyntia is an industrial biotech company delivering nature’s ingredients at scale both affordably and sustainably. Using cutting-edge biotechnology and proprietary R&D tools …See details»

Biosyntia raises $11.6m to launch world’s first bio-based vitamin B7

Jul 14, 2022 Biosyntia is an industrial biotech company delivering nature's ingredients at scale both affordably and sustainably. Using cutting-edge biotechnology and proprietary R&D tools …See details»

Joint press release by WACKER and Biosyntia

Biosyntia is considered a global leader in the development of fermentation processes for production of selected small molecules. The Danish biotech company has a proprietary …See details»

Our uniqueness - Biosyntia

We build full processes and deliver the ingredient Biosyntia is a product company, and we consider our technology as a critical tool to deliver dietary ingredients with added value. We …See details»

Biosyntia raises €17.5 million in Series B follow-on to advance ...

COPENHAGEN, Sept. 30, 2022 — The Danis biotech pioneer Biosyntia has closed a follow-on investment to its series B, making the round oversubscribed and totaling €17.5 million. …See details»

WACKER and Biosyntia Develop Large-Scale Production Process …

Biosyntia is driven by the prospect, that biology can replace chemistry and enable a more sustainable world for generations to come. Using nature’s own principle, our mission is to …See details»

NEW Press relaese - Biosyntia

Dec 21, 2021 ‍Biosyntia enters a new market “We are beyond excited about working with Lantana Bio on this! The agreement marks Biosyntia’s first step into botanical ingredients, a …See details»

linkstock.net © 2022. All rights reserved